Holen Sie sich die Stockscreener-App
14.53
0.00%
0.00
Handel nachbörslich:
14.53
Schlusskurs vom Vortag:
$14.53
Offen:
$14.53
24-Stunden-Volumen:
949.01K
Relative Volume:
0.47
Marktkapitalisierung:
$2.24B
Einnahmen:
$276.98M
Nettoeinkommen (Verlust:
$-59.46M
KGV:
-36.44
EPS:
-0.3987
Netto-Cashflow:
$-48.95M
1W Leistung:
-2.09%
1M Leistung:
+10.33%
6M Leistung:
-15.08%
1J Leistung:
+87.73%
1-Tages-Spanne:
$14.44
$14.86
1-Wochen-Bereich:
$12.36
$14.86
52-Wochen-Spanne:
$6.7747
$20.76
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Firmenname
Adaptive Biotechnologies Corp
Sektor
Branche
Telefon
206-659-0067
Adresse
1165 EASTLAKE AVE E, SEATTLE, WA
Compare ADPT vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
14.53 | 2.24B | 276.98M | -59.46M | -48.95M | -0.3987 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2025-09-30 | Eingeleitet | Guggenheim | Buy |
| 2025-06-18 | Eingeleitet | Craig Hallum | Buy |
| 2025-03-21 | Hochstufung | Goldman | Neutral → Buy |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-12-21 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Underperform |
| 2022-06-03 | Eingeleitet | Piper Sandler | Neutral |
| 2022-02-16 | Bestätigt | BTIG Research | Buy |
| 2022-02-16 | Bestätigt | BofA Securities | Buy |
| 2022-02-16 | Bestätigt | Goldman | Neutral |
| 2022-02-16 | Bestätigt | JP Morgan | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-03-03 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-08 | Fortgesetzt | BTIG Research | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Eingeleitet | Goldman | Buy |
| 2019-07-23 | Eingeleitet | BTIG Research | Buy |
| 2019-07-22 | Eingeleitet | BofA/Merrill | Buy |
| 2019-07-22 | Eingeleitet | Cowen | Outperform |
| 2019-07-22 | Eingeleitet | Goldman | Neutral |
| 2019-07-22 | Eingeleitet | Guggenheim | Buy |
| 2019-07-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Adaptive Biotechnologies Corp Aktie (ADPT) Neueste Nachrichten
Adaptive Biotechnologies schedules May 5 webcast for Q1 2026 results - Stock Titan
Adaptive Biotechnologies (ADPT) moves 5.8% higher: Will this strength last? - MSN
Adaptive Biotechnologies (ADPT) president Rubinstein sells $758k in stock By Investing.com - Investing.com India
Adaptive Biotechnologies (ADPT) president Rubinstein sells $758k in stock - Investing.com
Adaptive Biotechnologies (NASDAQ: ADPT) COO sells shares under 10b5-1 plan - Stock Titan
Insider Sell: Harlan Robins Sells Shares of Adaptive Biotechnologies Corp (ADPT) - GuruFocus
Adaptive Biotechnologies (ADPT) chief people officer sells $340k in stock By Investing.com - Investing.com India
Robins, Adaptive Biotechnologies CSO, sells $148,500 in stock By Investing.com - Investing.com Canada
Adaptive Biotechnologies (ADPT) chief people officer sells $340k in stock - Investing.com
Robins, Adaptive Biotechnologies CSO, sells $148,500 in stock - Investing.com
Adaptive Biotechnologies (ADPT) officer sells shares after option exercise - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) CSO sells 10,000 shares under 10b5-1 plan - Stock Titan
Adaptive Biotechnologies Corp. Opens with a 9.41% Gain, Outperforming S&P 500 - Markets Mojo
Adaptive Biotechnologies Hits Day High with 8.24% Surge in Stock Price - Markets Mojo
Insider Sell: Chad Robins Sells 120,595 Shares of Adaptive Biote - GuruFocus
Adaptive Biotechnologies president Rubinstein sells $990k in ADPT stock By Investing.com - Investing.com India
Adaptive Biotechnologies CEO Robins sells $1.76m in ADPT stock By Investing.com - Investing.com Australia
Adaptive Biotechnologies president Rubinstein sells $990k in ADPT stock - Investing.com
[Form 4] Adaptive Biotechnologies Corp Insider Trading Activity - Stock Titan
ADPT COO Rubinstein sells shares, exercises options under 10b5-1 plan - Stock Titan
Affiliate resale notice for ADPT (NASDAQ: ADPT) — 10,000 shares listed - Stock Titan
ADPT (ADPT) insider Chad M. Robins sells blocks totaling six‑figure proceeds - Stock Titan
ADPT (NASDAQ: ADPT) affiliate files Form 144 listing 22,564 shares for sale - Stock Titan
Adaptive Biotech Insider Sells $554K as Revenue Jumps 55%, but Here's What Investors Should Focus On - The Motley Fool
Affiliate sales disclosed for Adaptive Biotechnologies (NASDAQ: ADPT) in Form 144 - Stock Titan
Adaptive Biotechnologies Hits Day Low of $12.02 Amid Price Pressure - Markets Mojo
A Look At Adaptive Biotechnologies (ADPT) Valuation After Q4 2025 Beat And New Pfizer Agreements - Yahoo Finance
ADPT Technical Analysis & Stock Price Forecast - Intellectia AI
Adaptive Biotechnologies CSO Robins sells $799k in ADPT stock - Investing.com
Adaptive Biotechnologies CSO Robins sells $392,329 in ADPT stock - Investing.com
Adaptive Biotechnologies (NASDAQ:ADPT) COO Julie Rubinstein Sells 19,060 Shares - MarketBeat
Adaptive Biotechnologies president sells $553,693 in ADPT stock By Investing.com - Investing.com Australia
Adaptive Biotechnologies president sells $553,693 in ADPT stock - Investing.com
Adaptive Biotechnologies (ADPT) COO exercises options and sells 38K shares - Stock Titan
ADPT PE Ratio & Valuation, Is ADPT Overvalued - Intellectia AI
ADPT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Adaptive Biotechnologies (ADPT) president sells $751k in stock By Investing.com - Investing.com India
Adaptive Biotechnologies (ADPT) president sells $751k in stock - Investing.com
Adaptive Biotech (NASDAQ: ADPT) COO sells 57,180 shares in 10b5-1 plan - Stock Titan
Adaptive Biotech's President Trimmed Her Position. But what Remains is worth a look - The Motley Fool
A Look At Adaptive Biotechnologies (ADPT) Valuation After Recent Share Price Weakness - simplywall.st
Adaptive Biotechnologies (NASDAQ:ADPT) Trading Down 6.7%Here's What Happened - MarketBeat
Adaptive Biotechnologies’ president Rubinstein sells $802k in ADPT stock By Investing.com - Investing.com India
Adaptive Biotechnologies (ADPT) COO sells shares under Rule 10b5-1 plan - Stock Titan
Adaptive Biotechnologies’ president Rubinstein sells $802k in ADPT stock - Investing.com
Adaptive Biotech Insider Sale of 180,000 Shares Tied to Tax Event as Stock Jumps 70% in a Year - AOL.com
[SCHEDULE 13G/A] Adaptive Biotechnologies Corp Amended Passive Investment Disclosure - Stock Titan
Adaptive Biotechnologies (ADPT) falls 24.5% as execs dispose millions of stake - MSN
Finanzdaten der Adaptive Biotechnologies Corp-Aktie (ADPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):